Cardiovascular Management of Patients Undergoing Hematopoietic Stem Cell Transplantation
You are currently not logged in to PHD
To view this content, please login to your account, or within the login, click 'Create an Account' for guest access. To access AHA's full array of membership benefits, join or renew today!
Salim Hayek, MD, a cardiovascular specialist in cardio-oncology from the UTMB Health is joined by Amelia Langston, MD, a hematology and medical oncology specialist from Emory University to discuss their new AHA scientific statement on the cardiovascular management of patients undergoing hematopoietic stem cell transplantation (HSCT). They review the phases of HCST, the incidence of cardiovascular complications, long-term management, and the significance of survivorship post-transplant.
Recommended Videos
Management of Elevated Blood Pressure in the Acute Care Setting: Treatment
Management of Elevated BP in the Acute Care Setting
Management of Elevated Blood Pressure in the Acute Care Setting: Why This...
Management of Elevated BP in the Acute Care Setting: Key Takeaways
Data Science and AI to Enhance Personalization in Cardio Oncology Limitati...
Loading...
Save Video
Video is not available. Please check the URL.